Forus
PrivateLast Round
Series C
Sep 8, 2026
Est. Valuation
$3B
Total Funding Raised
$481M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Forus is a healthcare technology company that provides an AI-powered platform to automate prescription access, prior authorizations, and pharmacy coordination for medical practices and patients.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Medical AI, Workflow Automation, Pharma Supply Chain
Business Model
B2B2C
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forus Comparables
Compare Forus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cinnamon Health | 79% | |
| SamaCare | 79% | |
| Phil, Inc. | 77% |
Forus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 8, 2026 | ||||
| Series B | May 12, 2026 | ||||
| Series B | Feb 1, 2026 | ||||
| Series A | Nov 1, 2024 | ||||
| Series A | Jan 1, 2024 |
Forus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series C |
| Bain Capital Ventures | Series A, Seed, Series B, Series C |
| Neo | Series C |
| SV Angel | Series C |
| Vast Ventures | Series C |
| Avra | Series C |
| Thrive Capital | Series A, Seed, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2026
$150M round led by Bain Capital Ventures.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
Forus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Forus's valuation, stock price, and market status.
Is Tandem a public or private company?
Tandem is a private company.
What is the current stock price of Tandem?
Tandem is a private company with no public stock price. No recent secondary market data is available.
How much is Tandem worth (valuation)?
Tandem's valuation is estimated at $1.0B based on funding round data.
Can I buy Tandem stock?
Tandem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tandem's last funding round?
Tandem's most recent funding round was Series B on February 1, 2026.
Who are the main investors in Tandem?
Key investors in Tandem include Accel.
Will Tandem IPO soon?
No public IPO plans have been announced for Tandem.
How can I track Tandem secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tandem's secondary market activity and sign up for updates.